Implication of CD44 in adhesion-mediated overproduction of TGF-β and IL-1 in monocytes from patients with bone marrow fibrosis

British Journal of Haematology

Volumn 93, Issue 1, 1996, Pages 22-29

  Rameshwar, Pranela ^a   Chang, Victor T ^a,b   Gascón, Pedro ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

adhesion molecules; CD44; cytokines; monocytes; myelofibrosis

Indexed keywords

CELL ADHESION MOLECULE; COLLAGEN TYPE 1; FIBRONECTIN; HERMES ANTIGEN; HYALURONIC ACID; INTERLEUKIN 1; TRANSFORMING GROWTH FACTOR BETA;

ADULT; AGED; ARTICLE; CELL ACTIVATION; CLINICAL ARTICLE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; HUMAN TISSUE; MONOCYTE; MYELOFIBROSIS; PRIORITY JOURNAL;

ADULT; AGED; ANTIGENS, CD44; CELL ADHESION; COLLAGEN; FIBRONECTINS; HUMANS; HYALURONIC ACID; INTERLEUKIN-1; MIDDLE AGED; MONOCYTES; MYELOFIBROSIS; RECEPTORS, INTERLEUKIN-2; TRANSFORMING GROWTH FACTOR BETA;

EID: 0029970612     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.4631004.x     Document Type: Article

References (47)

1. Arrago, J.P., Poirier, O., Chomienne, C., D'Agay, M.F. & Najean, Y. (1986) Type III aminoterminal propeptide of procollagen in some haematological malignancies. Scandinavian Journal of Haematology, 36, 288-294.
2. Aruffo, A., Stamenkovic, I., Melnick, M., Underhill, C.B. & Seed, B. (1990) CD44 is the principal cell surface receptor for hyaluronate. Cell, 61, 1303-1313.
3. Baglin, T.P., Price, S.M. & Boughton, B.J. (1988) A reversible defect of platelet PDGF content in myeloproliferative disorders. British Journal of Haematology, 69, 483-486.
4. Bažil, V. & Hořejši, V. (1992) Shedding of the CD44 adhesion molecule from leukocytes induced by anti-CD44 monoclonal antibody stimulating the effect of a natural receptor ligand. Journal of Immunology, 149, 747-753.
5. Bevilacqua, M.P. (1993) Endothelial-leukocyte adhesion molecules. Annual Review of Immunology, 11, 767-804.
6. Bristol, L.A., Ruscetti, F.W., Brody, D.T. & Durum, S.K. (1990) IL-1α induces expression of active transforming growth factor-α in non-proliferating T cells via a post-transcriptional mechanism. Journal of Immunology, 145, 4108-4115.
7. Cabañas, C. & Hogg, N. (1991) Lymphocyte-fibroblast adhesion: a useful model for analysis of the interaction of the leukocyte integrin LFA-1 with ICAM-1. Federation of European Biochemical Societies Letters, 292, 284-288.
8. Cappio, F.C., Vigliani, R., Novarino, A., Caamussi, G., Campana, D. & Gavosto, F. (1981) Idiopathic myelofibrosis: a possible role for immune complexes in the pathogenesis of bone marrow fibrosis. British Journal of Haematology, 49, 17-21.
9. Carter, W.G. & Wayner, E.A. (1988) Characterization of the class III collagen receptor, a phosphorylated, transmembrane glycoprotein expressed in nucleated human cells. Journal of Biological Chemistry, 263, 4193-4201.
10. Charbord, P. (1986) Increased vascularity of bone marrow in myelofibrosis. British Journal of Haematology, 62, 595-596.
11. Cho, E.A., Riley, M.P., Sillman, A.L. & Quill, H. (1993) Altered protein tyrosine phosphorylation in allergic Th1 cells. Journal of Immunology, 151, 20-28.
12. Conrad, P., Rothman, B.L., Kelly, K.A. & Blue, M.L. (1992) Mechanism of periperal T cell activation by coengagement of CD44 and CD2. Journal of Immunology, 149, 1833-1839.
13. Dougherty, G.J., Landsdorp, P.M., Cooper, D.L. & Humphries, R.K. (1991) Molecular cloning of CD44R1 and CD44R2, two novel isoforms of the human CD44 lymphocyte 'homing' receptor expressed by hemopoietic cells. Journal of Experimental Medicine, 174, 1-5.
14. Greenberg, B.R., Woo, L., Veomett, I.C., Payne, C.M. & Ahmann, F.R. (1987) Cytogenetics of bone marrow fibroblastic cells in idiopathic chronic myelofibrosis. British Journal of Haematology, 66, 487-490.
15. Groopman, J.E. (1980) The pathogenesis of myelofibrosis in myeloproliferative disorders. Annals of Internal Medicine, 92, 857-858.
16. Haskill, S., Johnson, C., Eierman, D., Becker, S. & Warren, K. (1988) Adherence induces selective mRNA expression of monocyte mediators and proto-oncogenes. Journal of Immunology, 140, 1690-1694.
17. Hasselbalch, H. (1990) Idiopathic myelofibrosis: a clinical study of 80 patients. American Journal of Hematology, 34, 291-300.
18. Hasselbalch, H., Jans, H. & Nielsen, P.L. (1987) A distinct subtype of idiopathic myelofibrosis with bone marrow features mimicking hairy cell leukemia: evidence of an autoimmune pathogenesis, American Journal of Hematology, 25, 225-229.
19. Hasselbalch, H. & Junker, P. (1994) Serum laminin P1 in idiopathic myelofibrosis and related diseases. Leukemia Research, 18, 623-628.
20. Hasselbalch, H., Junker, P., Lisse, I., Lindqvist, U. & Laurent, A.E. (1991) Circulating hyaluronan in the myelofibrosis/osteomyelosclerosis syndrome and other myeloproliferative disorders. American Journal of Hematology, 36, 1-8.
21. Johnston, J.B., Dalal, B.I., Israels, S.J., Oh, S., McMillan, E., Begleiter, A., Michaud, G., Isreals, L.G. & Greenberg, A.H. (1995) Deposition of transforming growth factor-β in the marrow in myelofibrosis, and the intracellular localization and secretion of TGF-β by leukemic cells. Americal Journal of Clinical Pathology, 103, 574-582.
22. Kaelin, W.G. & Spivak, J.L. (1986) Systemic lupus erythematosus and myelofibrosis. American Journal of Medicine, 81, 935-938.
23. Katoh, S., McCarthy, J.B. & Kincade, P.W. (1994) Characterization of soluble CD44 in the circulation of mice: levels are affected by immune activity and tumor growth. Journal of Immunology, 153, 3440-3449.
24. Kimura, A., Hyodo, H., Nakata, Y. & Kuramoto, A. (1993) Chronic lymphocytic leukemia associated with bone marrow fibrosis: possible role of interleukin 1α in the pathogenesis. American Journal of Hematology, 43, 47-50.
25. Lee, H.M. & Rich, S. (1991) Co-stimulation off cell proliferation by transforming growth factor-β1. Journal of Immunology, 147, 1127-1133.
26. Lesley, J. & Hyman, R. (1992) CD44 can be activated to function as an hyaluronic acid receptor in normal murine T cells. European Journal of Immunology, 22, 2719-2723.
27. Martyré, M.C., Romquin, N., Le Bousse-Kerdiles, M.C., Chevillard, S., Benyahia, B., Dupriez, B., Demory, J.L. & Bauters, F. (1994) Transforming growth factor-β and megakaryocytes in the pathogenesis of idiopathic myelofibrosis. British Journal of Haematology, 88, 9-16.
28. McCarty, D.M. (1985) Fibrosis of the bone marrow: content and causes. British Journal of Haematology, 59, 1-7.
29. Miyake, K. & Kincade, P. W. (1990) A new cell adhesion mechanism involving hyaluronate and CD44. Current Topics in Microbiology and Immunology, 166, 87-90.
30. Miyake, K., Underhill, C.B., Lesley, J. & Kincade, P.W. (1990) Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition. Journal of Experimental Medicine, 172, 69-75.
31. Newman, M.J. (1993) Transforming growth factor beta and the cell surface in tumor progression. Cancer Metastasis Review, 12, 34-49.
32. Rameshwar, P., Denny, T., Stein, D. & Gascon, P. (1994) Monocyte adhesion in patients with bone marrow fibrosis is required for the production of fibrogenic cytokines: potential role for IL-1 and TGF-β. Journal of Immunology, 153, 2819-2830.
33. Rameshwar, P. & Gascón, P. (1992) Release of interleukin-1 and interleukin-6 from human monocytes by antithymocyte globulin: requirement for de novo synthesis. Blood, 80, 2531-2538.
34. Reilly, J.T. (1992) Pathogenesis of idiopathic myelofibrosis: role of growth factors. Journal of Clinical Pathology, 45, 461-464.
35. Reilly, J.T. (1994) Pathogenesis of idiopathic myelofibrosis: present status and future directions. British Journal of Haematology, 88, 1-8.
36. Reilly, J.T., Barnett, D., Dolan, G., Forrest, P., Eastham, J. & Smith, A. (1993) Characterization of an acute micromegakaryocytic leukaemia: evidence for the pathogeneiss of myelofibrosis. British Journal of Haematology, 83, 58-67.
37. Roberts, A.B., Sporn, M.B., Assoian, R.K., Smith, J.M., Roche, N.S., Wakefield, L.M., Heine, U.I., Liotta, L.A., Falanga, V., Kehrl, J.H. & Fauci, A.S. (1986) Transforming growth factor: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proceedings of the National Academy of Sciences of the United States of America, 83, 4167-4177.
38. Sampson, P.M., Rochester, C.L., Freudlich, B. & Elias, J.A. (1992) Cytokine regulation of human lung fibroblast hyaluronan (hyaluronic acid) production: evidence for cytokine-regulated hyaluronan (hyaluronic acid) degradation and human lung fibroblast-derived hyaluronidase. Journal of Clinical Investigation. 90, 1492-1503.
39. Sato, Y., Sada, T., Suda, J., Ohsaka, A., Kubota, K., Saito, M. & Miura, Y. (1986) Multilineage expression of haematopoietic precursors with an abnormal clone in idiopathic myelofibrosis. British Journal of Haematology, 64, 657-667.
40. Shimokado, K., Raines, E.W., Madtes, D.K., Barrett, T.B., Benditt, E.P. & Ross, R. (1985) A significant part of macrophage-derived growth factor consists of at least two forms of PDGF. Cell, 43, 277-286.
41. Siczkowski, M., Andrew, T., Amos, T.A.S. & Gordon, M.Y. (1993) Hyaluronic acid regulates the function and distribution of sulfated glycosaminoglycans in bone marrow stromal cultures. Experimental Hematology, 21, 126-130.
42. Spivak, J.L., Bender, B.S. & Quinn, T.C. (1984) Hematologic abnormalities in AIDS. American Journal of Medicine, 77, 224-228.
43. Taube, T., Franssila, K., Risteli, L., Risteli, J. & Elomaa, I. (1992) Monitoring of multiple myeloma and bone marrow fibrosis with aminoterminal propeptide of type III collagen. British Journal of Haematology, 82, 32-37.
44. Thiele, J., Braeckel, C., Wagner, S., Falini, B., Dienenmann, D., Stein, H. & Fishcher, R. (1991) Macrophages in normal human bone marrow and in chronic myeloproliferative disorders: an immunohistochemical and morphometric study by a new monoclonal antibody (PG-M1) on trephine biopsies. Virchows Archiv A: Pathological Anatomy, Histopathology, 421, 33-39.
45. Titius, B.R., Thiele, J., Schaefer, H., Kreipe, H. & Fischer, R. (1994) Ki-S1 and proliferating cell nuclear antigen expression of bone marrow macrophages. Acta Haematologica, 91, 144-149.
46. Vellenga, E., Marrink, J., Geest, S.V.D. & De Vries, E.G.E. (1985) Plasma fibronectin in idiopathic myelofibrosis. British Journal of Haematology, 60, 583-584.
47. Ward, H.P. & Block, M.H. (1971) The natural history of agnogenic myeloid metaplasia (AMM) and a critical evaluation of its relationship with the myeloproliferative syndrome. Medicine (Baltimore), 50, 357-420.